Clinical Research Vanackere SRL
Clinical Research Vanackere reported total assets of 263,927 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of Clinical Research Vanackere shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets +33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Clinical Research Vanackere's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 21 Jun 2022
Clinical Research Vanackere's financial analysis
- Solvency68.5%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Clinical Research Vanackere
Clinical Research Vanackere's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0656.693.859
- VAT number
- BE0656693859
- Peppol
- Registered · 0208:0656693859 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jun 2016
- Registered office
- 3390 Tielt-Winge
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Clinical Research Vanackere (SRL) has been based in Tielt-Winge since 2016, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 45,633 € and equity of 180,771 €; its revenue is not published. Its solvency stands at 68.5%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Clinical Research Vanackere
Companies in the same business, of comparable size and area, outside its group.
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- NO Headache Manufacture of basic pharmaceutical products Uccle · balance sheet 261,728 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Joos Clinical Projects Manufacture of basic pharmaceutical products Destelbergen · balance sheet 549,074 €
- APR Pharma Manufacture of basic pharmaceutical products Courcelles · balance sheet 244,955 €
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
Frequently asked questions about Clinical Research Vanackere
What is the revenue of Clinical Research Vanackere?
Clinical Research Vanackere files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Clinical Research Vanackere?
In Belgium, the VAT number is the company number prefixed with BE: BE0656693859 for Clinical Research Vanackere, if the company is VAT-registered. Its company number (CBE) is 0656.693.859.
Where is the registered office of Clinical Research Vanackere?
According to the CBE register, the registered office of Clinical Research Vanackere is in 3390 Tielt-Winge.
What is the equity of Clinical Research Vanackere?
At the close of the 2025 financial year, the equity of Clinical Research Vanackere amounts to 180,771 €, a solvency of 68.5% of total assets.
Who manages Clinical Research Vanackere?
The register lists 1 active mandates at Clinical Research Vanackere. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Clinical Research Vanackere
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →